INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Retina

• Publication date

  2016-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/IAE.0000000000000616PMID 26079477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

  2014cited by this paper
• Intravitreal Dexamethasone Implant for the Treatment of Macular Edema after Retinal Vein Occlusion in a Clinical Setting

  2013cited by this paper
• Dexamethasone Intravitreal Implant for Treatment of Patients with Persistent Diabetic Macular Edema

  2013cited by this paper
• Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice

  2013cited by this paper
• Intravitreal Dexamethasone Implant in Patients with Persistent Diabetic Macular Edema

  2012cited by this paper
• DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS

  2011cited by this paper
• Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

  2010cited by this paper
• Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

  2010influential reference
• Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.

  2010cited by this paper
• Hemodilution therapy in central retinal vein occlusion

  2004cited by this paper
• Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity.

  2001cited by this paper
• Effect of isovolemic hemodilution in central retinal vein occlusion

  2001cited by this paper
• The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells.

  1997cited by this paper
• [Morphology of early retinal lesions after experimental venous occlusion].

  1996influential reference
• A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.

  1989cited by this paper
• Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

  1985cited by this paper
• Mechanism of steroid action in ocular inflammation: Inhibition of prostaglandin production.

  1977cited by this paper
• Hemodilution therapy in central retinal vein occlusion One-year results of a prospective randomized study

  year unknowninfluential reference

• Safety Profile of Intravitreal Dexamethasone Implant to Manage Diabetic Macular Edema: A Systematic Review of Real-World Studies

  2025cites this paper
• Intravitreal Dexamethasone Implant for Patients With Central Retinal Vein Occlusion: Four-Year Outcomes in a Real-World Study

  2025cites this paper
• Visual outcomes and structural optical coherence tomography biomarkers after intravitreal dexamethasone implant for anti-vascular endothelial growth factor-resistant macular edema secondary to retinal vein occlusion

  2025cites this paper
• Intravitreal Dexamethasone Implant Switch after Anti-VEGF Treatment in Patients Affected by Retinal Vein Occlusion: A Review of the Literature

  2024cites this paper
• The effect of intravitreal dexamethasone implantation on diabetic macular edema refractory to anti-vascular endothelial growth factor treatment

  2022cites this paper
• Optical Coherence Tomography Reflectivity in Foveal Cysts: A Novel Biomarker for Early-Response Prediction of Diabetic Macular Edema Treated with Dexamethasone

  2022cites this paper
• Results of intravitreal dexamethasone implant (Ozurdex®) for retinal vascular diseases with macular edema: An observational study of real-life situations

  2022cites this paper
• Efficacy of single-dose intravitreal dexamethasone implantation for retinal vein occlusion patients with refractory macular edema: A systematic review and meta-analysis

  2022cites this paper
• Epiretinal membrane after branch retinal vein occlusion: Separation after dexamethasone implant injection

  2022cites this paper
• Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema

  2021cites this paper
• Ocular hypertension and severe intraocular pressure elevation after posterior subtenon injection of triamcinolone acetonide for various diseases.

  2020cites this paper
• The efficacy of dexamethasone implants following anti-VEGF failure for macular oedema in retinal vein occlusion

  2020cites this paper
• Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor

  2019cites this paper
• The Role of Steroids in the Management of Diabetic Macular Edema

  2019cites this paper
• Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)

  2019cites this paper
• Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant

  2019cites this paper
• Association between Hyperreflective Foci on Spectral-Domain Optical Coherence Tomography and Early Recurrence of Diabetic Macular Edema after Intravitreal Dexamethasone Implantation

  2019cites this paper
• Running title: DEX implant for retinal vein occlusion Efficacy of Dexamethasone Intravitreal Implant For Refractory Macular Edema Caused by Retinal Vein Occlusion

  2019cites this paper
• DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

  2019cites this paper
• The patterns and treatment of postoperative hemorrhage and hematoma in total endoscopic thyroidectomy via breast approach: experience of 1932 cases

  2019cites this paper
• Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab

  2019cites this paper
• Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery

  2018cites this paper
• Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy

  2018influential citation
• Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience

  2018cites this paper
• Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies

  2018cites this paper
• Efficacy of the Intravitreal Sustained-Release Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-Vascular Endothelial Growth Factor Therapy: Meta-Analysis and Clinical Implications.

  2017cites this paper
• Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’

  2017cites this paper
• Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion

  2017cites this paper
• Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert Panel.

  2017cites this paper
• Concurrent injection of dexamethasone intravitreal implant and anti-angiogenic agent in patients with macular edema

  2017cites this paper
• Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

  2017cites this paper
• Systemic Effects of Repeated Intraocular Dexamethasone Intravitreal Implant in Diabetic Patients: A Retrospective Study

  2017cites this paper
• OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.

  2017cites this paper
• Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion

  2017cites this paper
• Intravitreal Dexamethasone Implant ( Ozurdex ) for Macular Edema Secondary to Retinal Vein Occlusion

  2017cites this paper
• Short-term Effect of Intravitreal Dexamethasone Implant on Diabetic Macular Edema with Epiretinal Membrane

  2017cites this paper
• Sistemas genéticos para un nuevo abordaje del riesgo de progresión de la retinopatía diabética

  2016cites this paper
• Genetic systems for a new approach to risk of progression of diabetic retinopathy.

  2016cites this paper
• EFFICACY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR REFRACTORY MACULAR EDEMA CAUSED BY RETINAL VEIN OCCLUSION

  2016cites this paper
• Diabetic macular oedema: pathophysiology, management challenges and treatment resistance

  2016cites this paper
• Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

  2016cites this paper
• Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment

  2016cites this paper
• Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

  2015cites this paper
• International Medical Case Reports Journal Dovepress Long-lasting Corneal Endothelial Graft Rejection Successfully Reversed after Dexamethasone Intravitreal Implant

  year unknowncites this paper